Advertisement Quintiles Transnational acquires Bio-Trials - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Quintiles Transnational acquires Bio-Trials

Quintiles Transnational has announced that its Latin American subsidiary has purchased Bio-Trials, a leading Central American clinical research organization with headquarters in Panama and offices in Costa Rica, Guatemala, Ecuador and Peru.

Bio-Trials provides clinical monitoring, clinical site coordination, regulatory support, study management and supply distribution services.

Jeff Thomis, president of global clinical development services for Quintiles, said: “The acquisition of Bio-Trials gives Quintiles an experienced, well-established team as well as access to an experienced network of independent investigators in the increasingly important Central American region. Our customers are increasingly including Central America as part of their global drug development program. The Bio-Trials team will be a welcome addition to our Latin America group.”